Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe
23/10/2023 23:28
Oct 23 (Reuters) - Opsens Inc OPS.TO :
* OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE
SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE
Source text for Eikon: ID:nCNWxb02ja
Further company coverage: OPS.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe